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ABBREVIATIONS AND ACRONYMS 
 
A   peak late diastolic mitral inflow velocity 
APLAX apical long axis 
AGA   appropriate for gestational age 
ANOVA  analysis of variance  
AVC   aortic valve closure 
BMI  body mass index 
BSA   body surface area 
CI   cardiac index 
CO   cardiac output 
DBP   diastolic blood pressure 
DT   deceleration time 
E  peak early diastolic mitral inflow velocity  
e′  peak early diastolic myocardial velocity 
ECG   electrocardiogram 
ECS   echo comet score 
EF  ejection fraction 
GLS  global longitudinal strain 
HR  heart rate 
INF-LAT  inferolateral wall 
IVS   interventricular septum 
LA  left atrium/atrial 
LV  left ventricle/ventricular  
LVEDD  left ventricular internal diameter at end diastole 




LVESD  left ventricular internal diameter at end systole 
LVESV left ventricular end-systolic volume 
LVOT  left ventricular outflow tract  
LVOT D left ventricular outflow diameter 
MAP   mean arterial pressure 
MAPSE  mitral annular plane systolic excursions 
NPIS  National Perinatal Information System  
PLR   passive leg raising 
PVR  peripheral vascular resistance 
SBP   systolic blood pressure 
s’   peak systolic myocardial velocity 
SGA   small for gestational age 
SRe   global early diastolic strain rate 
SV   stroke volume 
SW  stroke work 
VTI   left ventricular outflow tract velocity-time integral  
2ch  2-chamber view 





Objective. The objective of this study was to assess whether echocardiographic 
parameters in combination with lung ultrasound can detect dynamic changes in 
hemodynamic status, cardiac function and lung congestion in women with severe features 
of preeclampsia and healthy controls immediately before and in the first days after 
delivery. We hypothesized that women with severe features of preeclampsia more 
frequently present with impaired left ventricular diastolic function, have higher degree of 
lung congestion that is related to impaired diastolic function parameters and are less fluid 
responsive compared with healthy pregnant women.  
Methods. 30 severe preeclamptic women and 30 healthy term controls were evaluated 
within 1 day before delivery, 1 day post-delivery and 4 days post-delivery. At each 
examination standard two-dimensional, pulsed wave and tissue Doppler 
echocardiography was performed. Left ventricular myocardial deformation parameters 
were assessed by two-dimensional speckle tracking imaging. Lung ultrasound was 
performed by the 28-rib interspaces technique and Echo Comet Score (ECS) was obtained 
as the sum of B-lines representing the amount of extravascular lung water. Fluid 
responsiveness was assessed by measuring changes in left ventricular stroke volume with 
passive leg rising and it was defined as an increase in stroke volume of at least 12%.  
Results.  
Hemodynamic characteristics  
Women with severe features of preeclampsia had significantly higher arterial blood 
pressures (mean arterial pressure: median 110 (range 103 – 119) mmHg vs. 88 (81 – 96) 
mmHg, p < 0.001) and peripheral vascular resistance (1694 (1480 – 1871) dynes×s×cm-
5 vs. 1411 (1173 – 1612) dynes×s×cm-5, p = 0.004), while heart rate (77 (70 – 89) bpm 
vs. 75 (69 – 84) bpm, p = 0.736) and stroke volumes (70 (61 – 78) ml vs. 68 (57 – 76) ml, 
p = 0.194) were comparable between both groups.  
Left ventricular systolic and diastolic function 
Ejection fraction was similar in both groups at all examinations (before delivery: 66 (64 
– 71)% vs. 66 (61 – 67)%, p = 0.061; 1 day post-delivery: 65 (62 – 70)% vs. 64 (62 – 




however, peak systolic myocardial velocities (s’) at the septal and lateral mitral annulus 
and global longitudinal strain values (GLS) were lower in preeclamptic women 4 days 
post-delivery (s’ at the septal mitral annulus: 7.4 (6.6 - 7.8) cm/s vs. 8.1 (7.9 - 9.3) cm/s, 
p = 0.001; GLS:  ‒21.7 (‒22.6 to ‒20.8)% vs. ‒23.0 (‒23.9 to ‒21.8)%, p = 0.027). At all 
assessments peak early diastolic myocardial velocities (e’) were significantly lower (e’ at 
the septal mitral annulus before delivery: 8.7 (7.0 - 10.3) cm/s vs. 9.0 (8.2 - 10.7) cm/s, p 
= 0.062; 1 day post-delivery: 8.2 (7.2 - 9.6) cm/s vs. 9.8 (8.7 - 11.0) cm/s, p = 0.001; 4 
days post-delivery: 8.5 (7.7 - 9.6) cm/s vs. 10.3 (9.0 - 12.1) cm/s, p < 0.001) and the ratio 
of the peak velocity of early diastolic mitral inflow (E) to e’ (E/e’) was significantly 
higher in preeclamptic women than in controls (before delivery: 8.2 (6.3 - 10.1) vs. 6.3 
(5.3 - 7.7), p = 0.002; 1 day post-delivery: 8.6 (7.6 - 10.2) vs. 6.9 (6.2 - 7.7), p = 0.001; 4 
days post-delivery: 8.3 (7.1 - 9.0) vs. 6.8 (5.9 - 7.3), p = 0.003).  
Lung ultrasound and fluid responsiveness 
ECS was significantly higher in preeclamptic women than in controls before delivery (16 
(9 – 25) vs. 6 (2 – 7), p < 0.001) and 1 day post-delivery (15 (8 – 26) vs. 9 (6 – 14), p = 
0.007), but not 4 days post-delivery (7 (2 – 13) vs. 4 (2 – 8), p = 0.091). Significant 
positive correlations between ECS and E/e’ were found before and immediately post-
delivery in preeclamptic group (Spearman, before delivery: r = 0.572, p = 0.001; 1 day 
post-delivery: r = 0.442, p = 0.018). Fluid responsiveness was observed in significantly 
more controls than in women with severe features of preeclampsia (12 (43%) vs. 3 (11%), 
p = 0.014) before delivery. 
Conclusions. Preeclampsia with severe features is associated with impaired diastolic 
function parameters that persist in the first days after delivery. Preeclamptic women have 
greater amount of extravascular lung water before and immediately post-delivery 
compared with healthy controls and lung congestion correlates with impaired parameters 
of diastolic function. Worsening of systolic function parameters 4 days after delivery in 
preeclamptic women might indicate subtle systolic dysfunction, which could become 
unmasked with the effect of augmented volume load related to fluid mobilization in the 
postpartum period. This finding seems to corroborate our results of passive leg raising 
test showing that the majority of preeclamptic women were fluid non-responsive and as 






Classification of hypertensive disorders during pregnancy 
Hypertensive disorders of pregnancy include 1) chronic (pre-existent) hypertension; 2) 
pregnancy induced hypertension, which is further divided into preeclampsia 
(characterized by new-onset hypertension and either proteinuria or end-organ dysfunction 
after 20 weeks of gestation) and gestational hypertension (characterized by new-onset 
hypertension after 20 weeks of gestation without signs and symptoms of end-organ 
dysfunction); and 3) chronic hypertension with superimposed preeclampsia 1-3. 
Diagnostic criteria for preeclampsia and preeclampsia with severe features (formerly 







Table 1. Diagnostic criteria for preeclampsia. Adapted from ref. 1. 
Blood pressure • Greater than or equal to 140 mmHg systolic or greater than 
or equal to 90 mmHg diastolic on two occasions at least 4 
hours apart after 20 weeks of gestation in a woman with a 
previously normal blood pressure  
• Greater than or equal to 160 mm Hg systolic or greater than 
or equal to 110 mmHg diastolic, hypertension can be 
confirmed within a short interval (minutes) to facilitate 
timely antihypertensive therapy 
And 
Proteinuria • Greater than or equal to 300 mg per 24-hour urine collection 
(or this amount extrapolated from a timed collection)  
or 
• Protein/albumin ratio greater than or equal to 30 g/mol 
• Dipstick reading of 1+ (used only if other quantitative 
methods not available) 
Or in the absence of proteinuria, new-onset hypertension with the new onset of any of 
the following: 
Thrombocytopenia • Platelet count less than 100x109/L  
Renal insufficiency • Serum creatinine concentration greater 97 µmol/L or a 
doubling of the serum creatinine concentration in the 
absence of other renal disease  
Impaired liver 
function 
• Elevated blood concentrations of liver enzymes (to twice 
normal concentration)  
Pulmonary edema  









Table 2. Diagnostic criteria for preeclampsia with severe features (any of the 
following). Adapted from ref 1. 
• Systolic blood pressure of 160 mmHg or higher, or diastolic blood pressure of 110 
mmHg or higher on two occasions at least 4 hours apart while the patient is on bed 
rest (unless antihypertensive therapy is initiated before this time) 
• Thrombocytopenia (platelet count less than 100x109/L) 
• Impaired liver function as indicated by abnormally elevated blood concentrations 
of liver enzymes (to twice normal concentration), severe persistent right upper 
quadrant or epigastric pain unresponsive to medication and not accounted for by 
alternative diagnoses, or both 
• Progressive renal insufficiency (serum creatinine concentration greater 97 µmol/L 
or a doubling of the serum creatinine concentration in the absence of other renal 
disease) 
• Pulmonary edema 
• New-onset cerebral or visual disturbances 
 
Epidemiology of preeclampsia 
Preeclampsia complicates 2 to 8% of pregnancies and remains one of the leading causes 
of maternal as well as perinatal morbidity and mortality worldwide 4,5. It is a complex 
multiorgan disease potentially involving the kidney, liver, brain and cardiovascular and 
hematologic systems. Preeclampsia with severe features occurs in approximately 0.5% of 
pregnancies with an incidence of 0.1 to 2.7% in the different regions 6. Deaths in 
preeclamptic patients are due to intracranial hemorrhage and cerebral infarction, acute 
pulmonary edema, hepatic failure or rupture and bleeding such as may occur with 
disseminated intravascular coagulation or placental abruption. 
The incidence of preeclampsia in Slovenia is 2 to 3% (data from the National Perinatal 
Information System - NPIS). Five of 36 (13.8%) maternal deaths in Slovenia between 
2000 and 2014 were due to preeclampsia; and hemorrhagic stroke was the cause of death 
in all five cases (National Institute for Public Health data) (Figure 1). Moreover, 




of all very preterm births (births at < 32 weeks of gestation when risks for neonatal 















Figure 2. Preeclampsia as a cause of very preterm birth (< completed 32 weeks of 
gestation) in 2003-2012, National Perinatal Information System data for Ljubljana 
Maternity Hospital. 
 
Besides the immediate short-term mortality and morbidity that may occur from the 
disease during pregnancy, preeclampsia is also associated with long-term risks. Over the 
past 10 years lots of data has accumulated indicating that a woman who has had a 
preeclamptic pregnancy is at an increased risk of cardiovascular disease later in life 1,7-13. 
 
Pathogenesis of preeclampsia 
The etiology and molecular basis of preeclampsia are not fully understood. There is 
evidence of underlying genetic, immunological and environmental factors 14. Principal 
pathology lies in the impaired development of placental vasculature resulting in relative 
placental hypoperfusion and ischemia 15,16. Antiangiogenic factors released from the 
placenta into maternal circulation provoke generalized maternal endothelial dysfunction 
and systemic hypertension. Endothelial dysfunction is the basis for the multiple clinical 
manifestations of the disease.  Evidence of genetic predisposition comes from the findings 
that preeclampsia may run in families 17. Many of the gene variants associated with 




pre-existing endothelial damage might be the common principal pathology in women 
susceptible to developing preeclampsia and cardiovascular disease later in life 18,19. 
Therefore, it has been proposed that failure of the maternal cardiovascular system to adapt 
to pregnancy may be the primary mechanism leading to secondary placental dysfunction 
in preeclampsia 20.  
 
Cardiovascular changes in normal pregnancy 
During pregnancy the cardiovascular system undergoes a set of physiological changes 
due to increased metabolic demand of the uteroplacental fetal unit, which requires 
adequate uteroplacental circulation. There is an increase in blood volume leading to an 
increase in venous preload. Cardiac output increases due to an earlier increase in stroke 
volume, followed by an increase in heart rate later during gestation (Figure 3). On the 
other side, there is a decrease in peripheral vascular resistance leading to a decrease in 
left ventricular (LV) afterload 21. Correspondingly, there is initial decrease in systemic 
blood pressure, which reaches its lowest value at mid-pregnancy and begins to increase 
again in the last trimester to pre-pregnancy values (Figure 3).  
Following labor, cardiac output further increases due to the relief of the inferior vena cava 
compression and autotransfusion from the uterus, as well as mobilization of the fluid from 
the extravascular space. In the first weeks postpartum cardiac output subsequently 














Figure 3. Hemodynamic changes in pregnancy, during labor and postpartum. 
Adapted from Cornetter and Ross-Hesselink 23.  
(CO, cardiac output; PVR, peripheral vascular resistance; MAP, mean arterial pressure) 
 
Hemodynamic changes during pregnancy are physiological basis for cardiac remodeling. 
There is progressive increase in LV end-diastolic and end-systolic dimensions, wall 
thickness and mass, consistent with a more spherical shape of the LV and the development 
of eccentric remodeling or hypertrophy. There is an increase of left atrial dimensions 
reflecting an increased preload. These parameters gradually recover after delivery but 
may remain above normal values until 6 months postpartum 21,24.  
Data on LV function during pregnancy are relatively inconsistent, partly due to the non-
uniform cardiovascular response to pregnancy among women 21. However, different 
methodology, study population heterogeneity related to race, gestational age and 
anthropometric factors, measurement variability and load-dependency of 
echocardiographic parameters may explain the discrepancies in the results. Some authors 
reported preserved parameters of LV systolic function throughout pregnancy including 
ejection fraction, fractional shortening, tissue Doppler myocardial systolic velocity as 




However, in other studies, the authors demonstrated a decrease in parameters of LV 
systolic function in the last trimester of pregnancy 24,27,28. The authors concluded that late 
pregnancy reduction of LV systolic indices reflects physiological adaptation to persistent 
increase in volume load 27,29.  
Regarding echocardiographic parameters of diastolic function, the majority of data shows 
higher peak velocity of the early diastolic mitral inflow (E) and longer deceleration time 
(DT) of the E wave compared to non-pregnant women. In the last trimester, progressive 
increase in peak velocity of late diastolic mitral inflow (A) starts to dominate resulting in 
a decrease in E/A ratio. No change in the ratio of E wave and early diastolic myocardial 
velocity (e’) E/e’ which is an estimate of the LV filling pressure, has been found during 
pregnancy 26,30-32. In a study by Melchiorre, et al. 33 who followed previous version of 
European recommendations for the evaluation of LV diastolic function 34, the authors 
found that almost one fifth of pregnancies at term met diagnostic criteria for diastolic 
dysfunction, mainly representative of impaired myocardial relaxation. Previous studies 
also reported altered pulsed wave and tissue Doppler diastolic parameters to some extent 
in late compared to earlier pregnancy 24,32,35,36. It has been postulated that impaired 
diastolic and systolic LV parameters observed in a proportion of women at the end of 
pregnancy may reflect cardiac maladaptation instead of normal physiological adaptation 
to chronic volume overload 33.  
 
Cardiovascular changes in women with preeclampsia 
Hemodynamic changes  
Several studies have examined hemodynamic changes in women with preeclampsia, yet 
there is heterogeneity in results, which can be explained by methodological limitations 
and many confounding factors related to altered loading conditions. The hemodynamic 
abnormalities can range from high to low cardiac output and high to normal peripheral 
vascular resistance. It is believed that the most representative hemodynamic pattern in 
preeclampsia is low cardiac output and high peripheral vascular resistance reflecting high 
LV afterload. These data were demonstrated in the largest, prospective study using 
invasive hemodynamic monitoring with a Swan-Ganz pulmonary artery thermodilution 




using noninvasive monitoring with impedance cardiography the authors observed a 
gradual increase in peripheral vascular resistance and a gradual decrease in cardiac output 
from normal pregnancy to pregnancy-induced hypertension and preeclampsia group. The 
most increased peripheral vascular resistance and the most reduced cardiac output were 
observed in preeclamptic group with fetal growth restriction 38. 
A hyperdynamic model of preeclampsia with high cardiac output was demonstrated in a 
longitudinal study of 400 primigravidas who were monitored during pregnancy with 
Doppler echocardiography. High cardiac output and normal peripheral vascular resistance 
were found during preclinical phase of the disease in women who developed 
preeclampsia; with the clinical onset of preeclampsia a shift to low cardiac output and 
high peripheral vascular resistance was noticed 39. Moreover, high cardiac output 
observed in some studies could also be the treatment effect, as the recruited patients were 
receiving antihypertensive medications, magnesium sulfate or intravenous fluids 37,40,41.  
In a study by Valensise, et al. 42 the authors noted two different hemodynamic states in 
preclinical phase of preeclampsia: low cardiac output - high vascular resistance in women 
who developed early-onset preeclampsia (< 34 weeks of gestation) versus high cardiac 
output - low vascular resistance in late-onset preeclampsia (≥ 34 weeks of gestation). 
Other studies demonstrated that preeclampsia that occurs earlier in gestation and is 
associated with fetal growth restriction is related to low cardiac output and high peripheral 
vascular resistance, while in later and term gestation preeclampsia, fetuses tend to be 
larger and there is a high cardiac output, low peripheral vascular resistance and raised 
intravascular volume hemodynamic profile 43,44.  
In accordance, recent data have shown that hemodynamic characteristics of preeclampsia 
seem associated with the presence or absence of fetal growth restriction rather than related 
to gestational age at onset; therefore, early-onset and late-onset preeclampsia cannot be 
considered as different disease processes 45. Fetal growth restriction was strongly 
associated with high peripheral vascular resistance whether or not in combination with 
preeclampsia. Preeclampsia without fetal growth restriction, however, had the same 
hemodynamic profile, namely high cardiac output, at late as well as early-onset 45. Fetal 
growth restriction more commonly coexists with preeclampsia at early gestation and is 
uncommon in late-onset preeclampsia, which could explain to some degree the results of 




Preeclampsia is also associated with arterial stiffness and endothelial dysfunction, which 
may persist after delivery 48,49. Intravascular volume in preeclampsia is thought to be 
depleted as a result of capillary leakage generated by endothelial dysfunction, rise in 
capillary hydrostatic pressure and decreased plasma oncotic pressure, predisposing 
preeclamptic women to pulmonary edema 50,51.  
Geometric and functional changes of the heart  
In response to increased LV afterload the heart in women with preeclampsia undergoes 
specific remodeling characterized by thicker LV wall and increased LV mass compared 
with healthy pregnant women 52-54. LV geometry changes tend to be more pronounced in 
women with early-onset preeclampsia 55.  
Previous studies on LV systolic function were limited on conventional echocardiographic 
parameters which are very dependent on loading conditions 56. Some authors found 
reduced LV fractional shortening and ejection fraction in patients with preeclampsia 
compared with healthy pregnant women 53,57, whereas others showed no changes 52 or 
even increased fractional shortening in conjunction with increased cardiac output. This 
was observed in untreated preeclamptic patients and explained by hyperdynamic model 
of preeclampsia 58. Bamfo, et al. 59 found that longitudinal systolic myocardial velocity 
measured by tissue Doppler imaging, a relatively less load dependent index, was 
decreased in preeclamptic patients with fetal growth restriction similarly to normotensive 
fetal growth restriction pregnancies.  
More recent studies have evaluated LV systolic function in preeclampsia with myocardial 
deformation imaging. Melchiorre, et al. 60 who used tissue Doppler based technique, 
found no differences in global deformation indices between women who developed 
preeclampsia at term and healthy controls. However, more impaired deformation 
parameters and worse cardiac remodeling were detected in women with preterm or early-
onset preeclampsia compared with those with preeclampsia at term or late-onset 
preeclampsia indicating preterm preeclampsia as a more severe form of the disease 28,61. 
Shahul, et al. 62 assessed myocardial deformation by two-dimensional speckle tracking-
derived method and demonstrated reduced global longitudinal strain (GLS) in women 





Furthermore, there is evidence that myocardial deformation may remain impaired also 
months after delivery 63-65. These findings may be consistent with epidemiological studies 
showing association between preeclampsia and subsequent cardiovascular risk 1,66. 
Several studies have demonstrated impaired diastolic parameters in preeclampsia. The 
majority of data showed exaggerated reduction of the E/A ratio indicative of impaired 
myocardial relaxation 53,57,61. In some studies, increased E/e’ ratio was found, especially 
in early-onset preeclampsia, suggesting higher LV filling pressures 53,67-69. Melchiorre, et 
al. reported diastolic dysfunction defined by integration of diastolic parameters according 
to the previous version of the recommendations 34 in 40% of women with preeclampsia 
at term and even in 14% of healthy controls 60. In a subsequent study the authors found 
that women with preterm preeclampsia have a more severe cardiac impairment than those 
with preeclampsia at term (26% vs. 4%; p < 0.05) 61. However, direct comparison of 
studies from the literature is difficult, as the timing of echocardiographic assessment in 
the studies was not comparable.   
Additionally, there is also a lack of comprehensive analysis of time dependent changes in 
both hemodynamic and systolic and diastolic parameters in patients with preeclampsia 
before and after delivery.  
 
Management of preeclampsia with severe features 
The optimal management of a woman with preeclampsia depends on disease severity and 
gestational age. Preeclampsia with severe features is generally regarded as indication for 
delivery, which is the definite treatment of the disease and reduces the risks of maternal 
and fetal complications. Conservative antepartum management, which allows 
corticosteroid administration for fetal lung maturation and maternal transfer to a tertiary 
center with a neonatal intensive care unit, is an option in selected preeclamptic patients 
remote from term (at < 34 weeks of gestation). The essential tasks in the management of 
preeclamptic patients are blood pressure control and treatment of multiple-organ 
complications, which can also occur postpartum, particularly in the first 48 hours. For 
treatment and prevention of eclamptic seizures magnesium sulfate is the drug of choice 
as it has been shown to be more effective in comparison to placebo, no treatment, several 




(systolic blood pressure > 160 mmHg, diastolic blood pressure > 110 mmHg, or mean 
arterial pressure > 125 mmHg) should be treated in pregnant and puerperal patients to 
prevent stroke 1.   
Fluid management during preeclampsia is essential yet challenging and there are no 
prospective studies on which to base decisions regarding administration of fluids. 
Therefore, guidelines are largely based on consensus and retrospective data. Insufficient 
intravascular volume results in decreased oxygen delivery to tissues and exacerbates 
organ (including placental) dysfunction 70. On the other hand, fluid excesses can lead to 
fluid extravasation and pulmonary edema 71. Risk of fluid over-resuscitation is especially 
high in preeclampsia due to endothelial dysfunction and resulting increased vascular 
permeability 5,51. Due to immediate increase in cardiac output with mobilization of 
extravascular fluids following delivery, risk of pulmonary edema is also high in early 
postpartum period 51. In the nineties, acute pulmonary edema was the leading cause of 
death in women with preeclampsia. The Confidential Enquiry into Maternal Deaths in the 
UK reported six maternal deaths between 1994 and 1996 due to adult acute respiratory 
distress syndrome that appeared to be related to poor fluid management in women with 
preeclampsia 72. On the basis of these reported deaths, recommendations on limiting 
intravenous fluids to not more than to 80 ml/hour have been made 1. Higher rates may, 
however, be necessary in some preeclamptic patients to adequately correct tissue 
hypoperfusion.  
 
Non-invasive assessment of maternal hemodynamics  
Accurate assessment of maternal hemodynamics is fundamental for appropriate fluid 
management in patients with severe features of preeclampsia. Outside pregnancy, 
transthoracic cardiac ultrasound (echocardiography) and lung ultrasound have become 
important diagnostic and monitoring tools in critically ill patients 73-77. Echocardiography 
allows rapid and non-invasive assessment of myocardial function, preload and filling 
pressure, whereas lung ultrasound can be used to determine the amount of extravascular 
lung water 78-80. In pilot studies on smaller number of critically ill pregnant patients, non-
invasive hemodynamic monitoring by echocardiography correlated well with invasive 




Previous studies have shown that both invasive hemodynamic monitoring and 
echocardiography in combination with lung ultrasound could facilitate fluid management 
in patients with preeclampsia 68,83,84,85,86.  
In critically ill patients, echocardiographic response of stroke volume to passive leg 
raising has been shown to predict fluid responsiveness 87. Fluid responsiveness is 
considered a state where an increase of venous return by fluid loading responses with an 
increase in stroke volume, indicating that a subject is at the steeper part of the Frank-
Starling cardiac function curve 88. As a subject becomes less fluid responsive, there is a 
risk for marked increase in extravascular lung water and tissue edema, because increased 
cardiac filling pressures are transmitted to increased hydrostatic pressures. This process 
is accentuated in patients with endothelial damage, like in sepsis, burns and presumably 
also in preeclampsia 89. Predicting fluid responsiveness aims to optimize circulation and 
organ perfusion while avoiding potentially deleterious fluid administration in critically ill 
patients. Brun, et al. 85 have demonstrated that in patients with severe preeclampsia fluid 
responsiveness can be predicted by an increase in the LV outflow tract velocity-time 
integral derived from the pulsed wave Doppler signal during passive leg raising.   
 
THE AIM OF THE STUDY 
The objective of this study was to assess whether echocardiographic parameters in 
combination with lung ultrasound can detect differences in hemodynamic status, cardiac 
function and lung congestion between patients with severe features of preeclampsia and 
control healthy women.  
 
HYPOTHESES 
1. Women with severe features of preeclampsia more frequently present with impaired 
parameters of diastolic LV function before and post-delivery in comparison with healthy 




2. Women with severe features of preeclampsia have higher degree of lung congestion 
before and post-delivery in comparison with healthy pregnant women.  
3. Women with severe features of preeclampsia are less fluid responsive compared to 
healthy pregnant controls. 
4. In women with severe features of preeclampsia lung congestion is related to 
echocardiographic parameters of impaired diastolic function. 
 
METHODS 
This prospective, observational case control study was performed at a single tertiary 
perinatal center (Department of Perinatology, Division of Gynecology and Obstetrics, 
University Medical Center Ljubljana, Ljubljana, Slovenia) from April 2015 to April 2017. 
All women included in the study provided written informed consent for study 
participation. The National Medical Ethics Committee approved the study (Project 
number 83/09/14, approved on 09/16/2014).  
 
Study population 
Consecutively admitted women with singleton pregnancies complicated by preeclampsia 
with severe features were included in the study at hospital admission. Preeclampsia with 
severe features was defined by the American College of Obstetricians and Gynecologist 
Task Force on Hypertension in Pregnancy recommendations (Tables 1 and 2) 1. Women 
were excluded if they had any comorbidities including chronic (pre-existent) or 
gestational hypertension, pre-existent or gestational diabetes mellitus, congenital or 
acquired heart disease or a history of tobacco smoking, alcohol or drug abuse during 
pregnancy. As per our institution’s standard protocol all patients were managed in a high 
dependency setting ante-partum and at least 24 hours post-delivery. Blood pressure was 
monitored continuously. Fluid intake and urine output were assessed hourly, and blood 
tests were repeated at least every 12 hours to monitor kidney function, electrolytes, full 
blood count, transaminases, and bilirubin. Magnesium sulfate was used for eclampsia 




Antihypertensive treatment with intravenous hydralazine or labetalol was used to 
maintain systolic blood pressure at < 160 mmHg and diastolic blood pressure at < 110 
mmHg. Intravenous and oral fluid intake was minimized, and neither fluids nor diuretics 
were routinely administered to treat oliguria. Delivery has been pursued following 
maternal stabilization at gestational ages of ≥ 34 0/7 weeks. For patients at < 34 0/7 weeks 
of gestation, administration of a single course of antenatal corticosteroids was attempted 
and pregnancy managed expectantly for up to 48 hours in the absence of maternal and/or 
fetal indications for immediate delivery. Vaginal delivery was considered unless a 
caesarean delivery was required for the usual obstetric indications.  
Controls were healthy pregnant women at term (≥ 37 0/7 weeks), matching the exclusion 
criteria cited above, with a singleton pregnancy and an estimated fetal weight appropriate 
for gestational age (AGA). They were included in the study at hospital admission for 
either planned cesarean section due to previous cesarean delivery or breech presentation 
or induction of labor.   
 
Study protocol 
At inclusion we measured body height and body weight of all participants. Body mass 
index was calculated by dividing body weight by the square of body height and body 
surface area was calculated using the Du Bois formula 90.  
The study groups underwent echocardiographic examination and lung ultrasound at 
bedside before delivery (within 24 hours before delivery), 1 day post-delivery (within 24 
hours post-delivery) and 4 days post-delivery. Systolic and diastolic blood pressures were 
measured at each examination in the semi-supine position with automatic oscillometric 
device on the right upper arm at the level of the heart. Fluid responsiveness was assessed 
before delivery (within 24 hours before delivery) and one day post-delivery (within 24 






Figure 4. Study protocol. 
 (RR, blood pressure; HR, heart rate) 
 
For additional analysis, the group of preeclamptic patients was further divided according 
to an estimated fetal weight into small for gestational age (SGA) and AGA. SGA was 
defined as a neonate with birth weight < 5th centile for gestational age. 
 
Ultrasound examination 
Ultrasound examination was performed using Vivid S6 scanner (GE Vingmed 
Ultrasound, AS, Horten, Norway) with a 3Sc-RC cardiac transducer for both 
echocardiography and lung ultrasound. All images were stored digitally for later offline 
analysis using dedicated software (EchoPac version 201; GE Vingmed Ultrasound AS).  
Echocardiographic examination 
Participants were studied at rest in the left lateral decubitus position and data acquired at 
end expiration from standard parasternal and apical windows. Heart rate was obtained 




were performed according to the joint recommendations of the American Society of 
Echocardiography and European Association of Echocardiography 91.  
Hemodynamic characteristics  
LV stroke volume was calculated as the product of LV outflow tract area and LV outflow 
tract velocity-time integral (VTI) derived from the pulsed wave Doppler signal in the LV 
outflow tract [equation (1)]. LV outflow tract area was calculated using the [equation (2)] 
91. Additionally, we calculated cardiac output [equation (3)], mean arterial pressure 
[equation (4)], peripheral vascular resistance [equation (5)] and stroke work [equation 
(6)] 92.  
LV SV = LVOT area × VTI       (1) 
LVOT area = (LVOT D)2 × π/4      (2) 
CO = LV SV × HR        (3) 
MAP = [systolic blood pressure + (2 × diastolic blood pressure)]/3 (4) 
PVR = 80 × MAP / CO       (5) 
SW = MAP × SV        (6)  
(LV SV, left ventricular stroke volume; LVOT, left ventricular outflow tract; VTI, left 
ventricular outflow tract velocity-time integral; LVOT D, left ventricular outflow 
diameter; CO, cardiac output; HR, heart rate; MAP, mean arterial pressure; PVR, 
peripheral vascular resistance; SW, stroke work) 
Cardiac geometry  
Parasternal long-axis measurements included LV internal diameter at end diastole 
(LVEDD) and at end systole (LVESD), interventricular septal wall thickness at end 
diastole (IVS), inferolateral wall thickness at end diastole (INF-LAT), and the LV outflow 
tract diameter measured in mid-systole. LV dimensions were measured directly on two-
dimensional images to avoid oblique sections of the LV and diameter overestimation 




the appropriate formula proposed by Lang, et al. 91. Relative wall thickness (RWT) was 
calculated as the ratio of two times INF-LAT to LVEDD. Concentric remodeling was 
defined as RWT of > 0.42 and a normal LV mass index (≤ 95 g/m2). Concentric and 
eccentric LV hypertrophy was defined as increased LV mass (LV mass index > 95 g/m2 
and/or LV mass > 162 g) with RWT > 0.42 and RWT ≤ 0.42, respectively.  
LV end-diastolic (LVEDV) and end-systolic (LVESV) volumes as well as left atrial end-
systolic volumes were measured in the apical 4- and 2-chamber views using the Simpson 
biplane method 91. LV sphericity index was calculated as the ratio of major LV internal 
diameter and minor LV internal diameter in apical 4-chamber view.  
Left ventricular systolic and diastolic function 
Using conventional echocardiographic parameters LV systolic function was assessed by 
calculating LV ejection fraction as the ratio of LV stroke volume and LV end-diastolic 
volume. Additionally, using M-mode in the apical 4-chamber view we measured mitral 
septal (MAPSEmed) and mitral lateral (MAPSElat) annular plane systolic excursions. 
Tissue Doppler imaging was used to measure peak systolic myocardial velocities at the 
septal (s’med) and lateral (s’lat) mitral annulus.  
LV diastolic parameters were obtained by pulsed wave Doppler in the apical 4-chamber 
view. At the tips of the mitral leaflets we measured mitral inflow velocities E and A, 
deceleration time (DT) of the E wave and calculated E/A ratio. Tissue Doppler imaging 
was used to measure early diastolic myocardial velocities at the septal (e’med) and lateral 
(e’lat) mitral annulus in the apical 4-chamber view. All measurements obtained by 
Doppler imaging were averaged from three consecutive cardiac cycles. Septal and lateral 
early diastolic velocity values were averaged and denoted by e’. The ratio E/e’ was 
calculated as E divided by e’ and was used as an estimation of LV filling pressure.  
In addition to standard diastolic parameters the ratio of early diastolic and systolic 
myocardial velocities (e′/s′) was calculated as it was proposed as an earlier parameter of 
impaired myocardial relaxation in clinical states where systolic function and filling 





Myocardial deformation parameters 
For myocardial deformation analysis two-dimensional echocardiographic images were 
acquired together with a simultaneous ECG signal from the apical 2-, 3- and 4-chamber 
views. Five consecutive cardiac cycles were recorded and digitally stored for offline 
analysis using manual two-dimensional speckle-tracking analysis software (EchoPac 
version 201; GE Vingmed Ultrasound, AS). The images with the highest quality with no 
less than 60 frames per second and the most optimal endocardial delineation were selected 
for analysis. The endocardial border was traced manually in the apical 2-, 3-, and 4- 
chamber views, adjusting the width of the region of interest to the myocardial wall 
thickness. Manual adjustments were made after visual inspection of the segmental 
tracking results throughout the cardiac cycle, with the goal of obtaining the best possible 
tracking in all myocardial segments. Segments with inadequate tracking were excluded 
from further analysis. Images with insufficient tracking in > 3 segments per LV were 
excluded from analysis. For data evaluation, LV was divided in 6 segments in each view 
and segmental strain was calculated for each of the 18 segments. GLS was defined as the 
average of the peak systolic strain values in all myocardial segments; more negative 
values indicating higher myocardial deformation. For data analysis we used absolute 
values of peak systolic mid-wall GLS. Global early diastolic strain rate (SRe) was 
calculated from the average of all 18 segments. The E/SRe ratio, as a marker of LV filling 
pressure, was calculated as E divided by the global SRe value.  
Opening and closure of aortic and mitral valves based on pulsed wave Doppler tracings 
were used to determine time intervals.  
 
Lung ultrasound  
Lung ultrasound was performed according to a systematic protocol in supine position 74,76. 
The Echo Comet Score (ECS) was obtained by the 28-rib interspaces technique dividing 
the chest wall in 12 areas on the left (from the second to the fourth intercostal space) and 
16 areas on the right (from the second to the fifth intercostal space) anterior and lateral 
hemithorax 76 (Figure 5). The amount of extravascular lung water was assessed by the 




hyperechoic reverberation artefacts that arise from the pleural line and extend to the 
bottom of the screen without fading and move synchronously with lung sliding. They 
represent a reverberation artefact through edematous interlobular septa or alveoli 75,76. 
The sum of B-lines found on each of the 28 chest wall areas yields the ECS denoting the 
amount of extravascular lung water 76. 
 
 
Figure 5. Distribution and the serial numbers of the 28-rib interspaces on the chest 






Fluid responsiveness was assessed by measuring changes in LV stroke volume (ΔSV) 
while performing passive leg rising (PLR) to a 45° angle for two minutes. LV stroke 
volume was calculated using [equation (1)]. LV outflow diameter was measured once, 
since it remains constant in a given subject. A second measurement of VTI was obtained 
within 30 seconds after the end of PLR and was compared with the baseline value. Fluid 
responsiveness was defined as a ΔSV of ≥ 12% 85,87,94.   
 
Statistical analysis 
For continuous variables, data were expressed as median together with the 25th and 75th 
percentiles (inter-quartile range). Categorical data were summarized as frequencies and 
percentages. For comparison between the study groups (severe preeclampsia vs. controls) 
and preeclamptic patients with SGA vs. AGA fetuses, Mann Whitney U-test was used for 
continuous variables and Chi-square test or Fisher`s exact test for categorical variables, 
as appropriate. Changes in parameters over time (before delivery vs. 1 day post-delivery 
vs. 4 days post-delivery) within each group were analyzed by repeated-measures 
ANOVA. Measurements before delivery vs. 1 day post-delivery, and 1 day post-delivery 
vs. 4 days post- delivery within each group were compared by Wilcoxon Signed Ranks 
test. Spearman’s correlation analysis was used to assess the relationship between ECS 
and diastolic function parameters. For all tests, a two-tailed p value ≤ 0.05 was considered 
statistically significant. The software used for statistical analysis was IBM SPSS Statistics 
for Windows Version 21.0 (Armonk, NY: IBM Corp.). 
 
RESULTS 
Study population characteristics 
Thirty women with preeclampsia with severe features and 30 healthy controls were 
included in the study; characteristics of the participants are shown in Table 3. No 




mass index before pregnancy and body mass index and body surface area at inclusion. 
Maternal ethnicity was Caucasian except for one woman in preeclamptic group, who was 
Asian. There were more nulliparous women in preeclamptic than in control group (p < 
0.001). None of the multiparous women had had preeclampsia or delivered preterm in 
their previous pregnancy. As expected from the study design, gestational age was higher 
in the control group (p < 0.001). There was a statistically non-significant trend towards a 
higher proportion of SGA neonates in preeclamptic group (p = 0.195). In the majority of 
participants (80% in preeclamptic vs. 87% in control group, p = 0.515) Cesarean section 
was performed. The high rate of Cesarean section among controls was a reflection of the 
criteria used for inclusion in this group. 
 
Table 3. Study population characteristics. Data are given as median (interquartile 




severe features  
(n = 30) 
Controls 
(n = 30) 
p 
Maternal age (years) 30 (24 - 36) 32 (28 - 36) 0.176 
BMI at inclusion (kg/m2) 28.9 (27.3 - 31.4) 28.0 (25.6 - 32.1) 0.464 
BMI before pregnancy (kg/m2) 23.6 (21.3 - 26.6) 23.0 (19.7 - 25.8) 0.433 
Nulliparous (n, %) 25 (83) 7 (23) < 0.001 
Gestational age (weeks) 32 5/7 (22 3/7 - 39 4/7) 38 3/7 (37 0/7 - 42 1/7) < 0.001 
Cesarean delivery (n, %) 24 (80) 26 (87) 0.515 
SGA (n, %) 5 (17) 1 (3) 0.195 
(BMI, body mass index; SGA, small for gestational age)  
  
Severe features of preeclampsia were: hypertension in all 30 (100%) cases; neurological 
symptoms in 14 (46%); visual disturbances in 4 (4%); elevated liver enzymes in 10 
(33%); thrombocytopenia in 3 (10%); and right upper abdominal pain in 5 (16%) patients. 
In the preeclampsia group, all 30 patients were treated with magnesium sulfate as per our 




was, therefore, administered as a continuous intravenous infusion of 1 g/h (as a 50 mL/h 
infusion) during the first two sonographic examinations: before delivery and 1 day post-
delivery. In 24 (80%) women with preeclampsia, magnesium sulfate was the only 
intravenous fluid intake. In 6 (20%) patients with preeclampsia, an additional 30 mL/hour 
infusion of crystalloids was administered before delivery and during the first ultrasound 
examination, while always limiting administration of intravenous fluid to 80 mL/h. 
Intravenous hydralazine was necessary for blood-pressure control in 6 (20%) women with 
preeclampsia before delivery. On day 4 postpartum, no woman with preeclampsia was 
receiving any intravenous fluid or medication. No woman in the control group received 
intravenous medication or intravenous fluid at the time of the sonographic examinations. 
 
Hemodynamic characteristics  
Hemodynamic parameters of the study population before delivery are reported in Table 
4. As expected, women with severe features of preeclampsia had significantly higher 
systolic, diastolic and mean arterial pressures concomitant with higher peripheral vascular 
resistance and stroke work compared with control subjects (p ≤ 0.001, respectively), while 
heart rate was comparable between both groups. No differences in stroke volumes and 
cardiac output were found between the groups. Similar differences in hemodynamic 






Table 4. Hemodynamic characteristics of the study population before delivery. 




severe features  
(n = 30) 
Controls 
(n = 30) 
p 
SBP (mmHg) 151 (136 - 159) 118 (111 - 124) < 0.001 
DBP (mmHg) 90 (86 - 100) 75 (69 - 82) < 0.001 
MAP (mmHg) 110 (103 - 119) 88 (81 - 96) < 0.001 
Heart rate (bpm) 77 (70 - 89) 75 (69 - 84) 0.736 
SV (ml) 70 (61 - 78) 68 (57 - 76) 0.194 
SV index (ml/m2) 37 (33 - 41) 36 (33 - 40) 0.195 
CO (ml/min) 5.5 (4.9 - 6.2) 5.0 (4.4 - 5.9) 0.312 
CI (ml/m2/min) 2.9 (2.6 - 3.3) 2.8 (2.4 - 3.2) 0.269 
Stroke work (mmHg×ml) 7947 (6865 - 8588) 5873 (5109 - 6451) < 0.001 
PVR (dynes×s×cm-5) 1694 (1480 - 1871) 1411 (1173 - 1612) 0.004 
(SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; SV, 
stroke volume; CO, cardiac output; CI, cardiac index; PVR, peripheral vascular resistance)  
 
There were no statistically significant differences in hemodynamic parameters when 
comparing preeclamptic patients with SGA vs. AGA neonates before delivery (mean 
arterial pressure: 110 (92 - 119) mmHg vs. 110 (105 – 120) mmHg, p = 0.269; cardiac 
output: 5.1 (4.0 – 5.2) ml/min vs. 5.6 (5.0 – 6.4) ml/min, p = 0.057; peripheral vascular 
resistance: 1874 (1588 - 2059) dynes×s×cm-5 vs. 1643 (1440 - 1799) dynes×s×cm-5, p = 
0.205) as well as on day 1 post-delivery (mean arterial pressure: 101 (97 – 112) mmHg 
vs. 112 (107 – 117) mmHg, p = 0.073; cardiac output: 5.0 (3.7 – 5.9) ml/min vs. 4.9 (4.0 
– 6.2) ml/min, p = 0.698; peripheral vascular resistance: 1588 (1328 - 2415) dynes×s×cm-
5 vs. 1770 (1529 - 1799) dynes×s×cm-5, p = 0.842). On day 4 post-delivery, however, 
cardiac output was significantly lower and peripheral vascular resistance significantly 
higher in SGA preeclamptic pregnancies compared to those with AGA fetuses/neonates: 
cardiac output: 3.7 (3.2 – 4.2) ml/min vs. 5.0 (4.4 – 5.8) ml/min, p = 0.007; peripheral 




dynes×s×cm-5, p = 0.004. Mean arterial pressure did not significantly differ on day 4 
post-delivery between SGA and AGA groups: 108 (102 - 108) mmHg vs. 106 (103 – 115) 
mmHg, p = 0.990.  
In the SGA group, there were no significant differences in mean arterial pressure (p = 
0.805, ANOVA), cardiac output (p = 0.131, ANOVA), and peripheral vascular resistance 
(p = 0.098, ANOVA) when comparing measurements before vs. 1 day vs. 4 days post-
delivery. Similarly, there were no significant differences over time in the AGA group (p 
= 0.716 for mean arterial pressure; p = 0.157 for cardiac output; and p = 0.129 for 
peripheral vascular resistance).  
 
Cardiac geometry  
Parameters of cardiac geometry before delivery are reported in Table 5. Women with 
severe features of preeclampsia had thicker IVS (p = 0.036) and INF-LAT (p = 0.043) 
wall, higher LV mass (p = 0.026) and LV mass index (p < 0.001) compared with controls. 
However, no significant differences in relative wall thickness, LV dimensions and 
sphericity index were detected between both groups. In the group of preeclampsia higher 
number of women showed LV remodeling compared with control group (p = 0.028). Left 
atrial volumes and volume indices were significantly larger in preeclamptic group than in 
controls (all p < 0.001). Similar differences in cardiac geometric parameters between both 
groups were noted 1 day and 4 days post-delivery except for the lower LVEDV 1 day 
post-delivery in the control group (median [interquartile range]: 100.0 ml (92.0 - 104.5 






Table 5. Cardiac dimensions of the study population before delivery. Data are given 




severe features  
(n = 30) 
Controls 
(n = 30) 
p 
LVEDD (mm) 47 (44 - 52) 47 (45 - 51) 0.801 
LVESD (mm) 30 (26 - 32) 31 (29 - 32) 0.106 
IVS (mm) 9.0 (8.0 - 10.0) 9.0 (7.8 - 9.0) 0.036 
INFLAT (mm) 9.0 (8.0 - 10.3) 8.0 (8.0 - 9.0) 0.043 
RWT 0.39 (0.32 - 0.44) 0.36 (0.33 - 0.39) 0.123 
LV mass (g) 142 (121 - 171) 130 (120 - 147) 0.026 
LV mass index (g/m2) 76 (71 - 90) 70 (66 - 75) < 0.001 
Cardiac geometry   0.028 
Normal geometry (n, %) 16 (53) 28 (94)  
Concentric remodeling (n, %) 5 (17) 1 (3)  
Concentric hypertrophy (n, %) 4 (13) 0 (0)  
Eccentric hypertrophy (n, %) 5 (17) 1 (3)  
LVEDV (ml) 107.5 (91.5 - 124.3) 104.0 (93.8 - 116.0) 0.49 
LVEDV index (ml/m2) 55.5 (51.8 - 63.0) 55.5 (52.0 - 61.3) 0.631 
LVESV (ml) 34.5 (28.5 - 44.5) 37.5 (31.8 - 42.0) 0.451 
LVESV index (ml/m2) 18.5 (16.0 - 22.0) 20.0 (17.0 - 22.3) 0.337 
Sphericity index 1.69 (1.56 - 1.86) 1.73 (1.58 - 1.84) 0.871 
LA volume (ml) 58.5 (50.8 - 69.3) 50.5 (45.0 - 57.5) 0.004 
LA volume index (ml/m2) 32.5 (29.0 - 36.0) 27.0 (25.5 - 31.0) < 0.001 
(LVEDD, left ventricular internal end-diastolic diameter; LVESD, left ventricular internal end-
systolic diameter; IVS, interventricular septal wall thickness at end diastole, INFLAT, 
inferolateral wall thickness at end diastole; RWT, relative wall thickness, calculated as the ratio: 
2 × INFLAT/LVEDD; LV, left ventricle; LVEDV, left ventricular end-diastolic volume; LVESV, 




According to parameters of cardiac geometry, only left atrial volume before delivery was 
significantly different between AGA and SGA preeclamptic pregnancies (AGA: 63.0 
(51.2 - 74.8) ml vs. SGA: 49.0 (41.7 - 56.3) ml; p = 0.022). There was also a trend, 
although not statistically significant, towards higher atrial volumes in AGA pregnancies 
on day 1 post-delivery (65.0 (54.6 - 75.4) ml vs. 58.0 (51.9 - 64.1) ml; p = 0.078) and on 
day 4 post-delivery (64.0 (54.1 - 73.9) ml vs. 56.0 (48.2 - 63.8); p = 0.055). 
 
Left ventricular systolic and diastolic function 
LV systolic and diastolic function parameters before delivery, 1 day and 4 days post-
delivery are presented in Tables 6-8.  
Women with severe features of preeclampsia had lower peak systolic myocardial 
velocities compared with controls at all assessments; the differences became statistically 
significant 4 days post-delivery for both septal and lateral mitral velocities; p = 0.001 and 
p = 0.04, respectively. Values of ejection fraction and MAPSE at the septal and lateral 
mitral annulus were similar between the groups at all assessments.  
Within preeclamptic and control group there were no significant changes in ejection 
fraction values over time (p = 0.55 and p = 0.61, respectively, ANOVA).  
Diastolic function parameters showed differences between preeclamptic and control 
group that were significant at certain assessments: higher A velocities (before delivery, p 
< 0.001; 1 day post-delivery, p = 0.022), lower E/A ratio (before delivery, p = 0.042) and 
longer DT (1 day post-delivery, p = 0.043; 4 days post-delivery, p = 0.019) in severe 
preeclampsia group. Overall e’ velocities at both septal and lateral mitral annulus were 
lower in women with preeclampsia than in controls (all p < 0.001 with an exception of 
e’med before delivery, p = 0.062). E/e’med, E/e’lat and E/e’ ratios were significantly higher 
in women with preeclampsia than in controls at all assessments (all p < 0.001) (Figure 6).  
In preeclamptic group, there were significant differences in the E/e’ ratios over time (p = 
0.02, ANOVA) (Figure 6). E/e’ values were significantly higher 1 day post-delivery than 




change was observed (p = 0.85, ANOVA). Figure 7 presents echocardiographic 
assessment of the E/e’ ratio in a representative preeclamptic woman and a healthy control. 
The ratios e’/s’ for septal and lateral mitral annulus were lower in preeclamptic group 
than in controls at all assessments; the difference was significant for lateral e’lat/s’lat 1 day 
(p = 0.003) and 4 days post-delivery (p = 0.042).   
There were no significant differences in LV systolic and diastolic function parameters in 







Table 6. Left ventricular systolic and diastolic function parameters of the study 




severe features  
(n = 30) 
Controls 
(n = 30) 
p 
Systolic function parameters 
EF (%) 66 (64 - 71) 66 (61 - 67) 0.061 
MAPSEmed (mm) 12.7 (11.6 - 14.4) 13.7 (12.5 - 14.7) 0.126 
MAPSElat (mm) 16.1 (14.5 - 17.8) 16.0 (14.4 - 17.5) 0.865 
s’med (cm/s) 7.7 (7.1 - 9.0) 8.3 (7.8 - 8.7) 0.178 
s’lat (cm/s) 8.6 (7.6 - 9.6) 9.3 (8.4 - 10.4) 0.038 
Diastolic function parameters 
E (cm/s) 83 (67 - 97) 70 (61 - 81) 0.086 
A (cm/s) 58 (49 - 71) 41 (38 - 52) < 0.001 
E/A 1.27 (1.10 - 1.66) 1.58 (1.28 - 2.07) 0.042 
DT (ms) 180 (138 - 201) 184 (159 - 198) 0.616 
e’med (cm/s) 8.7 (7.0 - 10.3) 9.0 (8.2 - 10.7) 0.062 
e’lat (cm/s) 11.0 (9.1 - 12.8) 12.8 (11.0 - 14.2) 0.004 
E/e’med 9.6 (7.6 - 11.1) 7.4 (6.2 - 9.2) 0.007 
E/e’lat 7.2 (5.6 - 9.3) 5.4 (4.8 - 6.9) 0.001 
E/e’  8.2 (6.3 - 10.1) 6.3 (5.3 - 7.7) 0.002 
e’med/s’med 1.07 (0.92 - 1.24) 1.13 (0.96 - 1.30) 0.300 
e’lat/s’lat 1.29 (1.05 - 1.50) 1.35 (1.21 - 1.49) 0.246 
(EF, ejection fraction; MAPSEmed, mitral septal annular plane systolic excursion; MAPSElat, 
mitral lateral septal annular plane systolic excursion; s’med, peak systolic myocardial velocity at 
the septal mitral annulus; s’lat, peak systolic myocardial velocity at the lateral mitral annulus; E, 
peak early diastolic mitral inflow velocity; A, peak late diastolic mitral inflow velocity; DT, 
deceleration time of the E wave; e’med, peak early diastolic myocardial velocity at the septal mitral 
annulus; e’lat, peak early diastolic myocardial velocity at the lateral mitral annulus; E/e’, ratio of 




Table 7. Left ventricular systolic and diastolic function parameters of the study 





severe features  
(n = 30) 
Controls 
(n = 30) 
p 
Systolic function parameters   
EF (%) 65 (62 - 70) 64 (62 - 66) 0.09 
MAPSEmed (mm) 12.8 (11.7 - 14.5) 13.0 (12.5 - 14.2) 0.487 
MAPSElat (mm) 16.4 (14.8 - 17.4) 15.9 (14.3 - 16.5) 0.194 
s’med (cm/s) 7.5 (6.5 - 8.1) 7.9 (7.5 - 8.7) 0.012 
s’lat (cm/s) 7.7 (6.9 - 8.9) 8.4 (7.3 - 9.3) 0.085 
Diastolic function parameters 
E (cm/s) 91 (75 - 100) 83 (76 - 93) 0.41 
A (cm/s) 53 (45 - 69) 45 (40 - 56) 0.022 
E/A 1.59 (1.31 - 2.03) 1.76 (1.55 - 2.02) 0.112 
DT (ms) 171 (152 - 202) 160 (139 - 174) 0.043 
e’med (cm/s) 8.2 (7.2 - 9.6) 9.8 (8.7 - 11.0) 0.001 
e’lat (cm/s) 10.9 (9.3 - 13.1) 14.1 (12.3 - 15.4) < 0.001 
E/e’med 10.4 (9.0 - 12.1) 7.9 (7.2 - 10.1) 0.007 
E/e’lat 7.7 (6.4 - 9.0) 5.9 (5.5 - 6.7) 0.001 
E/e’  8.6 (7.6 - 10.2) 6.9 (6.2 - 7.7) 0.001 
e’med/s’med 1.14 (1.03 - 1.30) 1.22 (1.13 - 1.33) 0.081 
e’lat/s’lat 1.43 (1.27 - 1.64) 1.64 (1.52 - 1.78) 0.003 
(EF, ejection fraction; MAPSEmed, mitral septal annular plane systolic excursion; MAPSElat, 
mitral lateral septal annular plane systolic excursion; s’med, peak systolic myocardial velocity at 
the septal mitral annulus; s’lat, peak systolic myocardial velocity at the lateral mitral annulus; E, 
peak early diastolic mitral inflow velocity; A, peak late diastolic mitral inflow velocity; DT, 
deceleration time of the E wave; e’med, peak early diastolic myocardial velocity at the septal mitral 
annulus; e’lat, peak early diastolic myocardial velocity at the lateral mitral annulus; E/e’, ratio of 




Table 8. Left ventricular systolic and diastolic function parameters of the study 





severe features  
(n = 30)  
Controls 
(n = 30) 
p 
Systolic function parameters 
EF (%) 64 (60 - 71) 65 (60 - 69) 0.592 
MAPSEmed (mm) 12.7 (11.0 - 13.9) 13.5 (12.7 - 15.0) 0.865 
MAPSElat (mm) 15.6 (14.6 - 17.0) 15.8 (14.6 - 17.0) 0.614 
s’med (cm/s) 7.4 (6.6 - 7.8) 8.1 (7.9 - 9.3) 0.001 
s’lat (cm/s) 8.1 (7.3 - 9.0) 8.7 (8.0 - 9.7) 0.040 
Diastolic function parameters 
E (cm/s) 80 (69 - 93) 82 (76 - 86) 0.712 
A (cm/s) 53 (47 - 63) 48 (44 - 55) 0.255 
E/A 1.43 (1.14 - 1.79) 1.65 (1.42 - 1.97) 0.172 
DT (ms) 181 (159 - 218) 162 (133 - 189) 0.019 
e’med (cm/s) 8.5 (7.7 - 9.6) 10.3 (9.0 - 12.1) < 0.001 
e’lat (cm/s) 11.1 (9.9 - 13.1) 13.6 (12.2 - 15.6) < 0.001 
E/e’med 9.6 (8.0 - 10.5) 7.7 (6.8 - 8.9) 0.006 
E/e’lat 7.1 (8.9 - 8.5) 5.7 (5.0 - 6.7) 0.006 
E/e’ 8.3 (7.1 - 9.0) 6.8 (5.9 - 7.3) 0.003 
e’med/s’med 1.16 (1.00 - 1.28) 1.19 (1.09 - 1.50) 0.094 
e’lat/s’lat 1.37 (1.14 - 1.69) 1.55 (1.38 - 1.77) 0.042 
(EF, ejection fraction; MAPSEmed, mitral septal annular plane systolic excursion; MAPSElat, 
mitral lateral septal annular plane systolic excursion; s’med, peak systolic myocardial velocity at 
the septal mitral annulus; s’lat, peak systolic myocardial velocity at the lateral mitral annulus; E, 
peak early diastolic mitral inflow velocity; A, peak late diastolic mitral inflow velocity; DT, 
deceleration time of the E wave; e’med, peak early diastolic myocardial velocity at the septal mitral 
annulus; e’lat, peak early diastolic myocardial velocity at the lateral mitral annulus; E/e’, ratio of 







Figure 6. Comparison of the E/e’ ratios in preeclampsia with severe features and 
control groups. E/e’ was higher in preeclamptic patients before delivery (p = 0.002), 1 
day post-delivery (p = 0.001), and 4 days post-delivery (p = 0.003). Changes in the E/e’ 
ratio over time were significant in preeclamptic (p = 0.02), but not in control group (p = 
0.85); * represents statistical significance. Data are presented with box-whisker plots with 
median and interquartile range and minimum and maximum data points. 







Figure 7. A representative example of pulsed wave Doppler (a, c) and tissue Doppler 
(b, d) curves in a study woman with preeclampsia with severe features (a, b) and a 
healthy control (c, d). Note the higher ratio of the peak velocity of early diastolic mitral 
inflow (E) to peak early diastolic myocardial velocity at the septal mitral annulus (e’) in 
a preeclamptic woman (E/e’ = 13.1) compared to the ratio in a healthy control (E/e’ = 
7.8). 
 
Myocardial deformation parameters 
Myocardial deformation parameters differed between women with severe features of 
preeclampsia and controls (Tables 9-11). However, GLS values were significantly lower 
in preeclamptic group only 4 days post-delivery (p = 0.027). Figure 8 presents 
longitudinal systolic strain curves in a study woman with preeclampsia with severe 
features. In preeclamptic group there were no significant changes in GLS values over 
time (p = 0.28, ANOVA). Similarly, there were no significant changes in GLS values 





Lower values were also obtained for SRe in preeclamptic group with significant 
differences before delivery (p = 0.015) and 4 days post-delivery (p = 0.02). Figure 9 
presents longitudinal diastolic strain rate curves in a study healthy woman. Significant 
difference in E/SRe ratio was found only before delivery (p = 0.008), with higher values 
in preeclamptic women.  
 
Table 9. Myocardial deformation parameters of the study population before 




severe features  
(n = 30) 
Controls 
(n = 30) 
p 
GLS (%) ‒21.5 (‒23.4 to ‒20.3) ‒22.2 (‒23.3 to‒ 21.1) 0.482 
SRe (s-1) 1.81 (1.61 - 2.20) 2.11 (1.96 - 2.31) 0.015 
E/SRe (cm/s2) 40.1 (36.3 - 46.9) 32.8 (27.0 - 38.7) 0.008 
(GLS, global longitudinal strain; SRe, global early diastolic strain rate; E, peak early diastolic 
mitral inflow velocity)  
 
Table 10. Myocardial deformation parameters of the study population 1 day post-




severe features  
(n = 30)  
Controls 
(n = 30) 
p 
GLS (%) ‒21.4 (‒22.4 to ‒20.7) ‒21.6 (‒23.1 to ‒20.6) 0.644 
SRe (s-1) 2.14 (1.89 - 2.36) 2.17 (2.00 - 2.31) 0.451 
E/SRe (cm/s2) 41.4 (36.3 - 46.9) 38.6 (32.9 - 41.1) 0.120 
(GLS, global longitudinal strain; SRe, global early diastolic strain rate; E, peak early diastolic 





Table 11. Myocardial deformation parameters of the study population 4 days post-




severe features  
(n = 30)  
Controls 
(n = 30) 
p 
GLS (%) ‒21.7 (‒22.6 to ‒20.8) ‒23.0 (‒23.9 to ‒21.8) 0.027 
SRe (s-1) 1.94 (1.82 - 2.24) 2.22 (2.06 - 2.67) 0.020 
E/SRe (cm/s2) 40.5 (35.4 - 47.0) 37.6 (33.2 - 39.3) 0.089 
(GLS, global longitudinal strain; SRe, global early diastolic strain rate; E, peak early diastolic 
mitral inflow velocity)  
 
Similarly to traditional parameters of LV systolic and diastolic function, we found no 
significant differences in novel myocardial deformation parameters in preeclamptic 
















Figure 8. A representative example of the measurement of global longitudinal strain 
(GLS) by two-dimensional speckle tracking method from apical long axis (APLAX), 
2-chamber (2ch) and 4-chamber (4ch) views with a bull’s-eye summary in a woman 
with preeclampsia with severe features. The bull-s-eye view provides the peak systolic 
mid-wall strain values of all individual left ventricular segments and the average of the 
strain values representing GLS, denoted by an arrow (→). In this example, GLS is 
decreased (-15.5%).  












Figure 9. A representative example of the measurement of longitudinal peak early 
diastolic strain rate (SRe) by two-dimensional speckle tracking method from apical 
long axis (APLAW), 2-chamber (2ch) and 4-chamber (4ch) views in a control 
subject. SRe is measured from the strain rate curves of each LV segment (peak values 
are denoted by white dots) and the values are averaged to obtain the global SRe. 
 
Lung ultrasound 
ECS was significantly higher in women with severe preeclampsia than in controls, both 
before delivery (p < 0.001) and 1 day post-delivery (p = 0.007); however, this difference 
was not present 4 days post-delivery (p = 0.091) (Figure 10).  
Figure 10 shows ECS in preeclamptic patients compared with controls before delivery 
and 1 day as well as 4 days post-delivery. Significant changes of ECS over time were 
observed in preeclamptic group (p = 0.01, ANOVA). ECS values were significantly lower 
before delivery vs. 1 day post-delivery (p = 0.001) and there was a significant decrease 
in ECS between days 1 and 4 post-delivery (p = 0.001). Significant difference in ECS 




revealed that there was a significant increase in ECS at day 1 post-delivery and 
subsequent decrease at day 4 post-delivery.  
 
 
Figure 10. Comparison of echo comet score (ECS) values in preeclamptic and 
control groups. ECS was higher in preeclamptic patients before delivery (p < 0.001), 1 
day post-delivery (p = 0.007), but not 4 days post-delivery (p = 0.091). Changes in ECS 
over time were significant in both groups (p = 0.01 for preeclampsia and p = 0.02 for 
controls); * represents statistical significance. Data are presented with box-whisker plots 
with median and interquartile range and minimum and maximum data points. 
 
Figure 11 presents lung ultrasound images before and post-delivery in a study woman 
with preeclampsia with severe features, showing the lung ultrasound pattern 








Figure 11. Lung ultrasound images in a woman with preeclampsia with severe 
features before delivery (a) and 1 day (b) and 4 days (c) post-delivery, showing B-
lines. Note a decrease in the number of B-lines or comet tails (*), illustrating a progressive 
decrease in extravascular lung water following delivery. 
 
Significant positive correlations between ECS and diastolic echocardiographic 
parameters were found; the strongest correlation was observed when ECS was compared 
with the E/e’ ratio (before delivery: r = 0.457, p < 0.001; 1 day post-delivery: r = 0.401, 
p = 0.003). However, the correlations were more pronounced when only preeclamptic 
group was analyzed (correlation between ECS and the E/e’ ratio in preeclamptic group 







Figure 12. Correlation between E/e’ ratio and echo comet score in preeclamptic 
patients before delivery. 








Figure 13. Correlation between E/e’ ratio and echo comet score in preeclamptic 
patients 1 day post-delivery. 
 (E/e’, ratio of the E and average of the septal and lateral e’ velocities) 
 
Fluid responsiveness 
Results of the PLR are presented in Table 12. There was significantly greater increase in 
stroke volume with PLR in the control group compared with preeclamptic group before 
delivery (p = 0.004), but not 1 day post-delivery. We observed a ΔSV of ≥ 12%, indicating 
fluid responsiveness in significantly more controls (n = 12; 43%) compared to 
preeclamptic women (n = 3; 11%) (p = 0.014) before delivery. The proportion of fluid 






Table 12. Fluid responsiveness data of the study population before and 1 day post-






ΔSV (%)     
- before 1.8 (‒1.5 - 7.7) 7.9 (2.7 - 20.2) 0.004 
- 1 day post-delivery 5.7 (‒0.6 - 11.6) 4.1 (‒1.8 - 8.0) 0.83 
Fluid responders  
(n/n of participants, %) 
   
- before 
3/27 (11) 12/28 (43) 0.014 
- 1 day post-delivery 4/27 (15) 2/21 (6) 0.683 
(ΔSV, the percent change in stroke volume measured from baseline to passive leg raising) 
 
DISCUSSION 
The main findings of the present work can be summarized as follows: a) preeclampsia 
with severe features is associated with impaired LV diastolic function parameters before 
delivery and in the first days post-delivery compared with healthy controls; b) 
preeclampsia with severe features is associated with higher degree of lung congestion 
before and immediately post-delivery compared with healthy controls; additionally, lung 
congestion is related to impaired parameters of diastolic function; c) only a small 
proportion of women with preeclampsia with severe features in our study cohort was fluid 
responsive. 
 
Hemodynamic and geometric changes 
Our data showed significantly higher peripheral vascular resistance and stroke work in 
preeclamptic women compared with control subjects. These results are consistent with 
previous hemodynamic studies, which demonstrated high peripheral vascular resistance 
and low cardiac output in preeclamptic patients 37,60. In a subgroup of women with SGA 




observed before and 1 day post-delivery. However, 4 days post-delivery we found 
significantly higher peripheral vascular resistance and lower cardiac output in the SGA 
compared to AGA group. This finding seems to corroborate the hypothesis of different 
hemodynamic patterns in preeclampsia and that the higher peripheral vascular resistance 
in preeclampsia is associated with fetal growth restriction 38,42,63. Similar hemodynamic 
profile in SGA and AGA groups at the time of delivery and immediately following 
delivery may be explained by the small number of SGA cases included, definition of SGA 
by itself and treatment with magnesium sulfate, which could affect echocardiographic 
parameters. It has to be noted that we analyzed SGA neonatal weight, which is not 
synonymous with fetal growth restriction. The latter with all its negative effects can be 
present even in AGA fetuses and is only diagnosed by serial exams showing growth 
restriction or “crossing the centiles” for gestational age. On the other hand, there are many 
SGA fetuses, whose small weight is not the consequence of placental dysfunction but 
their constitution or genetic growth potential. Our results on hemodynamic profiles in 
preeclampsia with vs. without SGA should not be overinterpreted. They do, however, 
generate a hypothesis that the high peripheral vascular resistance profile observed in 
preeclampsia with SGA becomes more pronounced in the first days following delivery. 
Related to previous studies early-onset preeclampsia and SGA/fetal growth restriction 
seem to be indicators of the more severe form of the disease. Furthermore, our findings 
indicate that altered hemodynamic status may persist in women with more severe forms 
of preeclampsia even days post-delivery. This could be clinically important as it could 
guide management of preeclamptic patients in the postpartum period. Further studies 
involving serial hemodynamic measurements in postpartum patients with preeclampsia 
should be performed to confirm or refute these findings of our study. 
We observed slightly but significantly thicker IVS and INFLAT wall and higher LV mass 
in women with preeclampsia than in controls, possibly reflecting an adaptive remodeling 
response to increased altered loading conditions. In preeclamptic group higher number of 
women showed LV remodeling compared with control group. Nevertheless, as 
preeclampsia with severe features appears as a short time pressure overload, it could 
therefore not induce remarkable geometric changes in LV mass and geometry 4,95.  
Similar to other studies, we also found significantly larger left atrial volumes in 




could not only be the result of increased preload, but also of impaired diastolic function 
parameters, which was revealed in preeclamptic group.   
 
Left ventricular systolic and diastolic function  
The results of our study demonstrated that systolic and diastolic parameters significantly 
differ between preeclamptic and control group. LV systolic function assessed by 
conventional echocardiographic parameters (ejection fraction, MAPSE and peak systolic 
myocardial velocity) did not differ between our study groups immediately before and 
post-delivery, while 4 days post-delivery we noted significantly lower peak systolic 
myocardial velocities in women with preeclampsia than in controls, that may suggest 
subtle impairment of systolic function.  
Previous studies on LV systolic function in preeclamptic women assessed by ejection 
fraction and/or fractional shortening have produced conflicting results 56,53,57,52. However, 
most of the data have shown reduced peak systolic Tissue Doppler myocardial velocity 
and concluded that myocardial contractility in preeclampsia is impaired 44,59,63,65. None 
of the studies so far have explored serial changes of systolic function parameters before 
and immediately after delivery, making the comparison with our results difficult.  
In the current work we assessed LV function also with novel myocardial deformation 
imaging. This promising technique enables an early detection of subtle myocardial 
functional changes and has been proved to be reproducible and feasible even in clinical 
use, although measurements vary among vendors and software versions 91. In our study 
cohort the median GLS values ± interquartile range were within normal limits proposed 
by the used vendor 91. Previously, several authors demonstrated impaired longitudinal 
strains with values below the normal range, despite of preserved ejection fraction in 
preeclamptic patients before delivery and also months postpartum 28,54,60,62-65,96. 
Discrepancies between our and previous data regarding strain parameters could be due to 
the differences in preeclamptic population with non-uniform hemodynamic pattern (as 
described above), variable loading conditions and different treatment regime. All women 
in our preeclamptic group were receiving magnesium sulfate before and 1 day post-




of echocardiographic examinations. It has been demonstrated that magnesium sulfate may 
cause sustained reduction in peripheral vascular resistance and an increase in cardiac 
index in patients with preeclampsia; hence may have an impact on echocardiographic 
parameters 40.  
Furthermore, in the studies so far different methods for strain measurements (doppler-
derived vs. speckle tracking) and different vendors and software for strain analysis were 
used that yield variable results and cannot be comparable 60,62,97. Additional factors that 
should be considered when interpreting the results are small number of patients in our 
study, relatively small differences in strain values and technical limitations of strain 
imaging which is highly sensitive to image quality.  
However, we found significantly lower GLS values in preeclamptic women than in 
controls 4 days post-delivery, but not before and 1 day post-delivery. These results are in 
line with previously mentioned results of peak systolic Tissue Doppler velocity, where 
difference was detected also only 4 days post-delivery.  
As both tissue Doppler and myocardial deformation parameters are very sensitive to 
loading conditions 98, loading changes should also be considered when these 
measurements are interpreted. From previous obstetrics studies, it is known that fluid 
mobilization from extravascular space occurs after delivery 21,22. This physiological 
phenomenon leads to increased volume load and consequently should augment 
myocardial contraction, according to the Frank-Starling force-length mechanism, as long 
as the contractility is normal 89,99. Decrease of deformation and peak systolic Tissue 
Doppler parameters with volume overload after delivery in our preeclamptic women 
could be explained by assuming that the heart already works on the flat or even 
descending portion of the Frank-Starling curve at the time of delivery and immediately 
postpartum; therefore force-length relationship would no longer operate effectively. This 
observation could indicate that volume overload after delivery might uncover subtle 
systolic dysfunction in preeclamptic women. An increase in preload would otherwise 
increase GLS values in fluid responsive subjects as demonstrated in a recent study of 
critically ill patients 100. Our results of passive leg raising test showed that the majority of 
preeclamptic women were fluid non-responsive before and immediately after delivery. 
This again indicated that the heart works on the flat portion of the Frank-Starling curve, 




In contrast to subtle changes of systolic dysfunction, the differences in diastolic 
parameters were more pronounced in our study population. This is not surprising, as 
parameters indicating diastolic dysfunction precede systolic impairment in most cardiac 
diseases and also have important prognostic value 101,102,103. While early diastolic mitral 
inflow velocity E is determined by LV relaxation, filling pressures and volume load, e’ is 
mainly a measure of myocardial intrinsic properties and reflects myocardial relaxation, 
relatively less affected by preload. Thus, the E/e’ ratio turns out to be proportional to the 
LV filling pressures and as such the E/e’ ratio has become clinically widely-used 
echocardiographic estimate of filling pressures 30,31,77,78,104,105. Although the majority of 
studies have shown a close correlation of the E/e’ ratio with LV filling pressures and its 
prediction is most reliable when the ratio is < 8 or > 15, there is a broad range of values 
in healthy people and an overlap of values with cardiac patients, which limit the 
diagnostic accuracy of the E/e’ ratio particularly in normal healthy subjects 104. Namely, 
in the presence of normal or enhanced LV relaxation, e’ has been shown to be related not 
only to LV relaxation, but also to preload, contractile state and restoring forces through 
end systolic volume 106-108.  
In our study, e’ velocities were lower and E/e’ ratios higher in preeclamptic than in control 
group, that might suggest impaired LV relaxation and higher LV filling pressures in 
preeclamptic women. These changes were observed before delivery and also in the first 
days post-delivery. Lower values were evident for both septal and lateral myocardial 
velocities; the later were suggested to be less influenced by preload 109. It should be noted, 
however, that in our study cohort the E/e’ ratios were within normal or intermediate 
reference range according to the guidelines and in only six (20%) preeclamptic cases the 
ratios were above estimated reference values for elevated LV filling pressure (E/e’med > 
15, E/e’lat > 13 and E/e’ > 14) 
104. Women with preeclampsia differed also in other 
Doppler diastolic parameters; the differences were small but reached significance at 
certain assessments and could be indicative of an early LV diastolic impairment. Other 
authors reported similar data of disturbed diastolic parameters in women with 
preeclampsia 53,59,60,67,69. In addition to standard diastolic function parameters, we also 
calculated the e′/s′ ratio, which was proposed as an earlier parameter of impaired 
myocardial relaxation in intensive care unit patients 93. Reduced ratio may reflect 
abnormal myocardial relaxation compared to preserved systolic function in states of 




associated with hyperdynamic circulation and increased stroke work, the e’/s’ ratio may 
be of value in identifying concealed myocardial impairment in pathological conditions. 
No studies have evaluated this parameter in pregnancy so far. Our results demonstrated 
lower e’/s’ ratios in women with preeclampsia than in controls that reached statistically 
significance 1 day and 4 days post-delivery, further confirming evidence of impaired 
diastolic function compared with healthy women.  
Myocardial deformation imaging can be also used in assessment of diastolic LV function; 
early diastolic strain rate (SRe) reflects myocardial lengthening and untwisting rate which 
is coupled to diastolic restoring forces and suction. In a recent study on healthy subjects 
and patients at risk for diastolic dysfunction with preserved ejection fraction SRe seemed 
to better detect diastolic function alterations compared with traditional diastolic 
parameters 110. Using SRe instead of tissue Doppler e’, which is limited to basal segments 
and is angle dependent, the E/SRe ratio has been shown to better predict LV filling 
pressure and prognosis in cardiac disease 111,112. In our study we found lower SRe values 
and higher E/SRe ratios in preeclamptic women compared with controls with significant 
differences at certain assessments, which confirm evidence of impaired diastolic function, 
albeit cannot demonstrate additional diagnostic value over traditional diastolic 
parameters.  
Therefore, we could confirm that parameters of LV diastolic function were impaired 
among women with severe preeclampsia and persisted also in the first days after delivery. 
We speculate that deterioration of systolic function parameters peak systolic Tissue 
Doppler velocity and GLS after delivery in preeclamptic women could be related to subtle 
systolic dysfunction, which becomes unmasked with the effect of augmented volume load 
related to fluid mobilization in the postpartum period. The augmented volume load could 
be indicated by our findings of the highest ECS and the E/e’ ratio immediately after 
delivery.    
 
Lung ultrasound  
Preeclampsia with severe features was associated with an increase in extravascular lung 
water before delivery with further increase immediately postpartum. The amount of 




day 4 postpartum we observed no difference in ECS between preeclamptic women and 
healthy controls. These findings are in accordance with well-established association of 
preeclampsia with a higher incidence of pulmonary edema 51. Furthermore, we found that 
lung ultrasound can identify increased levels of extravascular lung water in preeclamptic 
women before clinical signs of pulmonary edema appear; none of the patients included 
had clinical signs of pulmonary edema despite high ECS values. Therefore, in 
preeclamptic patients lung ultrasound could help reduce complications associated with 
fluid over-resuscitation and identify those that would need diuretic therapy.  
Additionally, amount of extravascular lung water, assessed by ECS, correlated well with 
the parameter of LV filling pressure (E/e’ ratio). The correlation was even more 
pronounced when only preeclamptic group was analyzed. However, increased LV filling 
pressure could explain only part of the ECS changes as previous studies demonstrated 
that the mechanism of pulmonary edema in preeclamptic women is associated with 
increased vascular permeability related to endothelial dysfunction as well as changes in 
intravascular hydrostatic and plasma oncotic pressure 4,51. 
 
Fluid responsiveness 
Echocardiographic assessment of fluid responsiveness by PLR could be used to identify 
women with preeclampsia who will respond to fluids by increasing their cardiac output. 
Such patients will benefit from further fluid administration when their cardiac output is 
inadequate to meet their metabolic demands. Based on our results, only a small proportion 
of women with severe preeclampsia were fluid responsive (before delivery 11% 
preeclamptic women versus 43% healthy controls, p = 0.014). Our findings are, however, 
in accordance with the impedance cardiography data, which showed 4 - 15% of pregnant 
women to be fluid responsive 113,114. Brun, et al. 85 found a higher (52%) proportion of 
fluid responsiveness in severe preeclampsia complicated by oliguria, which highlights the 







The present work emphasizes that evaluation of lung congestion and cardiac function can 
be an important part in the management of preeclampsia with severe features allowing to 
identify women at higher risk of life-threatening complications. Clinical examination 
alone cannot discriminate between the different hemodynamic patterns in severe 
preeclampsia. Simple and easy-to-use echocardiographic parameters in combination with 
lung ultrasound, can be used for assessing fluid responsiveness and fluid tolerance. 
Firstly, lung ultrasound seems a promising method for identifying women with severe 
preeclampsia in whom positive fluid balance should be avoided, as it may lead to 
pulmonary edema. Secondly, echocardiography could help clinicians to identify patients 
with severe preeclampsia who are still fluid responsive and in whom further fluid 
administration could be beneficial and the opposite: a patient with an echocardiographic 
evidence of elevated LV filling pressure is at increased risk for pulmonary edema. Lung 
ultrasound is relatively quick to learn and following appropriate training anesthesiologists 
and obstetricians could utilize it as a point-of-care investigation in obstetric complications 
75,76,80. 
 
Strengths and limitations of our study  
To our knowledge this is the first study to serially analyze and demonstrate dynamic 
changes in extravascular lung water and LV function in women with severe preeclampsia 
before delivery and in the first days post-delivery. Our observations suggest that recovery 
of hemodynamic changes in preeclampsia may be prolonged, exposing women to 
increased risk for cardiac decompensation and pulmonary edema for several days after 
delivery. Apart from traditional Doppler imaging we included in our study myocardial 
deformation, that is a promising echocardiographic modality with already proven clinical 
applications in several cardiac diseases 115. Diastolic strain rate has not been evaluated in 
preeclamptic population so far.  
The limitations of our study are inherent to the small study population. We intended to 
focus only on patients with severe features of preeclampsia, as these are critically ill 




clinical management. Unfortunately, there can be no optimal controls in these types of 
study owing to the specific characteristics of preeclamptic patients. Gestational age is 
known to be an important determinant of hemodynamic status in pregnancy. However, to 
match controls by gestational age, we would have to have included either patients with 
spontaneous preterm labor or those with medically indicated preterm delivery. In the first 
case, maternal hemodynamics would be influenced by labor itself and its possible 
infectious etiology. In the second case, medically indicated preterm delivery is most often 
performed, if not for hypertensive disorders of pregnancy, for fetal intrauterine growth 
restriction 116. This is most often due to placental malfunction, which again makes such 
patients non-optimal controls 117.  
In our study we did not analyze diastolic function by the evidence-based algorithms with 
integration of several diastolic function parameters 104, therefore we cannot draw firm 
conclusions on diastolic function and LV filling pressures in our study population. The 
majority of participants had none or trivial color Doppler signal of tricuspid regurgitation, 
therefore assessment of peak tricuspid regurgitation velocity was not feasible. 
Nevertheless, pulsed Doppler and Tissue Doppler velocities and the E/e’ ratios are simple 
and reproducible echocardiographic parameters that in spite of known limitations are 
most frequently used in clinical practice. Strain rate imaging, however, has several 
technical limitations and at present cannot be used in daily clinical practice.   
Assessing ECS with the 28-rib interspaces technique is time consuming. Further studies 
are needed to evaluate simplified techniques, such as the eight anterior regions method, 
which could be more suitable for everyday clinical practice. All ultrasound examinations 
and offline analysis were performed by a single investigator, thus avoiding inter-observer 
variability. Further studies will also be needed to assess reproducibility (i.e. intra-observer 
and inter-observer variability) of the measurements analyzed. Limitation of our study is 
also the lack of follow-up data when post-delivery hemodynamic and geometric 
parameters return to baseline values. Further studies are needed to better understand the 






Women with preeclampsia with severe features have greater amount of extravascular lung 
water immediately before and after delivery that could be in part caused by impaired LV 
diastolic function; therefore, optimal fluid balance is crucial to avoid complications in 
this vulnerable period. Only a small proportion of preeclamptic women are fluid 
responsive. In the first days after delivery extravascular lung water in preeclamptic 
women decreases, while diastolic function parameters are persistently impaired. After 
delivery myocardial deformation and systolic tissue Doppler parameters slightly 
decrease, which might reveal subtle systolic dysfunction, uncovered with the effect of 
augmented volume load related to fluid mobilization in the postpartum period. Our study 
confirms previous findings of subtle cardiac dysfunction in women with severe features 
of preeclampsia and provides extended cardiac and lung ultrasound data on serial 
dynamic changes before and in the first days after delivery. Cardiac ultrasound can be 
efficiently used as a non-invasive bedside technique for better management of 





POVZETEK DOKTORSKEGA DELA V SLOVENSKEM JEZIKU 
 
Uvod 
Preeklampsija je ena izmed oblik hipertenzivne bolezni v nosečnosti, ki prizadene 
približno 2 do 3 % nosečnic v Sloveniji (podatki Nacionalnega perinatalnega 
informacijskega sistema - NPIS). O težki preeklampsiji govorimo, kadar je povišanemu 
krvnemu tlaku in proteinuriji pridružena prizadetost enega ali več organskih sistemov 1-3 
(Tabela 2). V Sloveniji je bila v zadnjih desetletjih težka preeklampsija drugi 
najpogostejši vzrok za maternalno umrljivost (podatki Nacionalnega perinatalnega 
informacijskega sistema - NPIS) (Slika 1).   
Dosedanje raziskave hemodinamičnih sprememb pri preeklampsiji so dale različne 
rezultate, kar je posledica neenakosti med skupinami preiskovank, različnih preiskovalnih 
metod in tudi vpliva spremenljivih pogojev predobremenitve in poobremenitve srca na 
hemodinamične kazalce. Pri bolnicah s preeklampsijo so v raziskavah ugotovili dva 
hemodinamična vzorca: velik minutni volumen srca in nizka periferna žilna upornost ter 
majhen minutni volumen srca in visoka periferna žilna upornost 37,39,42. Slednji kaže na 
hujšo obliko bolezni in je bil pogosteje prisoten pri zgodnji preeklampsiji 38,42,44,55,57. 
Novejše raziskave kažejo, da sta nizek minutni volumen srca in visoka periferna žilna 
upornost povezana z zastojem rasti ploda, ki se sicer pogosteje pojavlja pri zgodnji 
preeklampsiji 45. Dosedanje ultrazvočne raziskave so pokazale spremembe kazalcev 
sistolične in diastolične funkcije pri nekaterih bolnicah s preeklampsijo, vendar rezultati 
niso povsem primerljivi zaradi različnih skupin preiskovank in različne metodologije 
28,57,59,60,63,69.   
Eden od življenje ogrožajočih zapletov težke preeklampsije je pljučni edem 1. 
Domnevajo, da je v nastanek pljučnega edema vpletenih več patofizioloških 
mehanizmov: povečana prepustnost kapilar ob endotelni disfunkciji, povečana periferna 
žilna upornost, zmanjšano ledvično delovanje, diastolična disfunkcija levega prekata in 
povečan venski priliv zaradi premika zunajcelične tekočine v žilni prostor v poporodnem 
obdobju 5,51. Z nadomeščanjem tekočin, s katerim preprečujemo okvaro organov zaradi 




tveganje za nastanek pljučnega edema 71. Za lažje vodenje in usmerjanje terapije pred in 
neposredno po porodu pri bolnicah s težko preeklampsijo je zelo koristna neinvazivna 
ocena hemodinamičnega stanja in srčne funkcije, ki jo omogoča ultrazvočna preiskava. 
Z ultrazvočnim pregledom srca lahko ocenimo hemodinamične kazalce, srčno funkcijo 
in odzivnost na tekočino, z ultrazvočnim pregledom pljuč pa stopnjo pljučne kongestije 
(zunajžilne tekočine v pljučih) 68,73,79,80,118.  
Uporabnost ultrazvočne preiskave pri nosečnicah s težko preeklampsijo je še slabo 
raziskana, prav tako nimamo podatkov kakšne so dinamične spremembe hemodinamičnih 
kazalcev in kazalcev srčne funkcije pred in v prvih dneh po porodu. 
 
Namen dela 
Namen raziskave je opredeliti uporabnost ultrazvočne preiskave srca in pljuč za oceno 
hemodinamičnega stanja, srčne funkcije in pljučne kongestije bolnic s težko 
preeklampsijo pred in v prvih dneh po porodu. 
 
Hipoteze  
1. Bolnice s težko preeklampsijo imajo pogosteje prisotne kazalce motene 
diastolične funkcije levega prekata pred in po porodu v primerjavi z zdravimi 
nosečnicami. 
2. Bolnice s težko preeklampsijo imajo večjo stopnjo pljučne kongestije pred in po 
porodu v primerjavi z zdravimi nosečnicami.  
3. Bolnice s težko preeklampsijo so manj odzivne na tekočino v primerjavi z 
zdravimi nosečnicami.  







Zasnova raziskave, opis preiskovank in metod 
Preiskovanke 
V raziskavo smo vključili 30 nosečnic, ki so izpolnjevale merila težke preeklampsije v 
skladu s smernicami in so bile sprejete v Porodnišnico Univerzitetnega kliničnega centra 
Ljubljana. Kontrolna skupina so bile zdrave nosečnice ob predvidenem terminu poroda. 
Izključitveni kriteriji so bili pridružene kronične bolezni, gestacijska arterijska 
hipertenzija in sladkorna bolezen, prirojene in pridobljene srčne bolezni ter kajenje. 
Preiskovanke so sodelovanje v raziskavi potrdile s podpisom. Raziskavo je odobrila 
Komisija Republike Slovenije za medicinsko etiko (mnenje št. 83/09/14, odobritev 
16.09.2014).   
Zasnova raziskave 
Preiskovankam v skupini s težko preeklampsijo in v kontrolni skupini smo opravili 
ultrazvočno preiskavo srca in pljuč dan pred porodom, dan po porodu in četrti dan po 
porodu. Ob vsakem pregledu smo izmerili krvni tlak z avtomatičnim oscilometričnim 
merilcem krvnega tlaka. Odzivnost na tekočino smo ocenili dan pred in dan po porodu 
(Slika 4). 
Ultrazvočna preiskava srca in pljuč 
Ultrazvočno preiskavo srca in pljuč smo opravili z ultrazvočnim aparatom Vivid S6 (GE 
Vingmed Ultrasound, AS, Horten, Norway) in 3Sc-RC kardiološko sondo. Za analizo 
smo posneli najmanj tri zaporedne srčne cikle. Vse posnetke smo shranili in jih analizirali 
s programsko opremo EchoPac (verzija 201, GE Vingmed Ultrasound AS).   
Preiskovankam smo opravili standardno transtorakalno ultrazvočno preiskavo srca po 
evropskih in ameriških priporočilih. Izmerili smo srčne dimenzije in debelino sten levega 
prekata, izračunali maso levega prekata in hemodinamične kazalce ter ocenili sistolično 
in diastolično srčno funkcijo s klasičnimi dvodimenzionalnimi, doplerskimi in tkivno 
doplerskimi metodami. V raziskavo smo vključili tudi meritve deformacije miokarda 
levega prekata z uporabo metode sledenja ultrazvočnega vzorca (ang. speckle tracking 
imaging). S to metodo smo ocenili globalni kazalec deformacije levega prekata v 
longitudinalni smeri (angl. global longitudinal strain - GLS), ki velja za občutljivejši 




zgodnjo diastolično hitrost deformacije miokarda (angl. global early diastolic strain rate 
- SRe), ki je novejši kazalec diastolične funkcije levega prekata 91,111.  
Ultrazvočni pregled pljuč smo opravili v ležečem položaju po protokolu 28 medrebrnih 
prostorov (Slika 5). Na osnovi prisotnosti in števila B linij smo ocenili stopnjo pljučne 
kongestije; vsota B linij v 28 medrebrnih prostorih je predstavljala količino zunajžilne 
pljučne tekočine (Echo Comet Score - ECS) 75,76.  
Odzivnost na tekočino  
Odzivnost na tekočino smo opredelili s spremembo utripnega volumna, ocenjenega s 
pulzno doplersko preiskavo ob pasivnem dvigu nog 85,87. Odzivnost na tekočino smo 
definirali kot povečanje utripnega volumna za ≥ 12% 94. 
Statistične metode  
Podatke smo statistično obdelali s programom SPSS 21.0 (IBM SPSS Statistics for 
Windows, Armonk, NY: IBM Corp.). Meritve dan pred porodom, prvi dan po porodu in 
četrti dan po porodu smo v skupini preeklamptičnih bolnic in v kontrolni skupini 
primerjali z Mann Whitney U-testom pri zveznih spremenljivkah in s Hi-kvadrat ali 
Fisherjevim testom pri kategoričnih spremenljivkah. Razlike spremenljivk znotraj 
posamezne skupine pred porodom, prvi dan po porodu in četrti dan po porodu smo 
ovrednotili z analizo variance (angl. ANOVA). Spearmanov koeficient korelacije smo 
uporabili za analizo povezanosti ECS in kazalcev diastolične funkcije levega prekata. Pri 
vseh testih smo kot statistično značilne upoštevali tiste razlike, pri katerih je bila vrednost 
p < 0,05).   
 
Rezultati 
Klinične značilnosti preiskovank  
Med skupinama ni bilo statistično značilnih razlik v starosti, indeksu telesne mase pred 
nosečnostjo in ob vključitvi v raziskavo. Skupina s preeklampsijo je imela nižjo 
gestacijsko starost in več prvorodnic v primerjavi s skupino zdravih nosečnic (p < 0,001) 




Hemodinamične značilnosti  
Preeklamptične bolnice so imele pričakovano višji sistolični, diastolični in srednji krvni 
tlak ter višjo periferno žilno upornost v primerjavi s kontrolno skupino (p ≤ 0,001). Med 
skupinama ni bilo statistično značilnih razlik v srčni frekvenci, utripnemu in minutnemu 
volumnu srca (Tabela 4).  
Geometrični kazalci srca  
Preeklamptične bolnice so imele debelejši prekatni pretin (p = 0,036) in inferolateralno 
steno (p = 0,043) ter večjo maso levega prekata (p < 0,001) v primerjavi z zdravimi 
nosečnicami. Med skupinama ni bilo razlik v relativni debelini sten, dimenzijah in 
indeksu sferičnosti levega prekata. Večji delež preoblikovanega levega prekata smo 
ugotovili v skupini preeklamptičnih nosečnic (p = 0,028). Volumen levega preddvora je 
bil statistično značilno večji v skupini nosečnic s težko preeklampsijo (p < 0,001) (Tabela 
5).  
Sistolična in diastolična funkcija levega prekata  
Preeklamptične bolnice so imele značilno nižje vrednosti najvišje sistolične hitrosti 
miokarda (s') v primerjavi s kontrolno skupino četrti dan po porodu (s' na medialnem 
mitralnem obroču: p = 0,001 in s' na lateralnem mitralnem obroču: p = 0,040), nismo pa 
našli razlik v iztisnem deležu levega prekata in longitudinalnem gibanju mitralnega 
obroča (angl. mitral annular plane systolic excursion - MAPSE) (Tabele 6-8). 
Preeklamptične bolnice so imele tudi značilno nižje vrednosti GLS četrti dan po porodu 
v primerjavi s kontrolno skupino (p = 0,027) (Tabele 9-11).   
V skupini bolnic s težko preeklampsijo in v skupini zdravih nosečnic ni bilo razlik v 
iztisnem deležu levega prekata in GLS med meritvami pred porodom, prvi dan po porodu 
in četrti dan po porodu.  
Med skupinama smo ugotovili razlike v kazalcih diastolične funkcije levega prekata. 
Vrednosti zgodnje diastolične hitrosti miokarda (e') na septalnem in lateralnem mitralnem 
obroču so bile značilno nižje (p < 0,001), razmerje zgodnje diastolične hitrosti mitralnega 
vtoka E in e' (E/e') pa značilno večje v skupini s preeklampsijo v primerjavi s kontrolno 





V skupini s preeklampsijo so bile med posameznimi preiskavami pomembne spremembe 
razmerja E/e' (p = 0,02, ANOVA): razmerje E/e’ je bilo pomembno večje prvi dan po 
porodu v primerjavi z razmerjem pred porodom (p = 0,001) in četrti dan po porodu (p = 
0,001) (Slika 6). 
Pri preeklamptičnih bolnicah smo našli tudi značilno nižje vrednosti SRe pred porodom 
(p = 0,015) in četrti dan po porodu (p = 0,020) (Tabele 9-11).  
Pljučna kongestija  
Seštevek B-linij je bil večji v skupini s preeklampsijo v primerjavi s kontrolno skupino 
pred porodom (p < 0,001) in prvi dan po porodu (p = 0,007), ni pa se pomembno 
razlikoval štiri dni po porodu (Slika 10). V skupini s preeklampsijo smo ugotovili 
pomembne spremembe v ECS (p = 0,01, ANOVA): ECS je bil nižji pred porodom v 
primerjavi z ECS prvi dan po porodu (p = 0,001) in znova nižji četrti dan po porodu (p = 
0,001). Podobne spremembe v ECS smo našli tudi v kontrolni skupini (p = 0,02, 
ANOVA): povečanje ECS prvi dan po porodu in nato znižanje četrti dan po porodu (Slika 
10).  
Dokazali smo tudi pomembno povezavo med ECS in E/e' v skupini s preeklampsijo pred 
porodom (r = 0,572, p = 0,001) in prvi dan po porodu (r = 0,442, p = 0,018) (Slika 12, 
13).  
Odzivnost na tekočino  
Pred porodom je bilo več zdravih nosečnic odzivnih na tekočino (12; 43%) v primerjavi 
s preeklamptičnimi bolnicami (3; 11%) (p = 0,014). Dan po porodu med skupinama ni 
bilo razlik v odzivnosti na tekočino (Tabela 12).  
 
Zaključki 
1. Pri bolnicah s težko preeklampsijo so pogosteje prisotni kazalci motene 
diastolične funkcije levega prekata pred porodom in v prvih dneh po porodu v 
primerjavi z zdravimi nosečnicami. Po porodu se pri preeklamptičnih bolnicah 




funkcije, ki se razkrije ob povečani volumski obremenitvi srca zaradi premika 
tekočine iz zunajžilnega prostora.   
2. Bolnice s težko preeklampsijo imajo večjo stopnjo pljučne kongestije pred in po 
porodu v primerjavi z zdravimi nosečnicami. Stopnja pljučne kongestije je 
povezana s kazalci diastolične disfunkcije. V prvih dneh po porodu se pri 
preeklamptičnih bolnicah stopnja pljučne kongestije zmanjša, medtem ko kazalci 
motene diastolične funkcije vztrajajo.  
3. V naši raziskavi je bila večina bolnic s težko preeklampsijo neodzivna na 
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